Current and Future Therapies for Hepatitis C Virus Infection

T. Jake Liang(National Institutes of Health), Marc G. Ghany(National Institute of Diabetes and Digestive and Kidney Diseases)
New England Journal of Medicine
May 15, 2013
10.1056/nejmra1213651
Cited by 487Open Access
Full Text

Abstract

Only 20 years after the discovery of the hepatitis C virus, a cure is now likely for most people with chronic infection. This review considers current therapy and the present landscape of drug development for hepatitis C.

Related Papers

The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gisa Gerold, Thomas Pietschmann|Digestive Diseases|2014|4.9k
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah, Justina Groeger, Abraham D. Flaxman et al.|Hepatology|2012|2.5k
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
Catherine L. Jopling, MinKyung Yi, Alissa M. Lancaster et al.|Science|2005|2.5k
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
Bryce D. Smith, Rebecca L. Morgan, Geoff A. Beckett et al.|PubMed|2012|998
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
T. Jake Liang, Barbara Rehermann, Leonard B. Seeff et al.|Annals of Internal Medicine|2000|875